China Pharma (NYSE:CPHI) Coverage Initiated at StockNews.com

Equities researchers at StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHIGet Free Report) in a research note issued to investors on Saturday. The firm set a “hold” rating on the stock.

China Pharma Stock Performance

Shares of China Pharma stock opened at $0.20 on Friday. The firm’s 50-day moving average is $0.23 and its 200 day moving average is $0.24. China Pharma has a 1 year low of $0.17 and a 1 year high of $0.74. The company has a current ratio of 0.79, a quick ratio of 0.26 and a debt-to-equity ratio of 0.22.

China Pharma Company Profile

(Get Free Report)

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.

Further Reading

Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.